Tissue-Engineered “Metastases”: Treatment of Hepatic Colon Tumors With a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist . J. Can. Res. Updates 2021, 1 (1), 69-77. https://doi.org/10.6000/1929-2279.2012.01.01.11.